Literature DB >> 8542242

Alpha interferon as an immunomodulator in the treatment of patients with tumors.

M Alvarez-Mon1, O J Salmerón, L Manzano, M Rodríguez-Zapata, E Reyes, L M Vaquer, J Carballido.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8542242     DOI： 10.1007/bf01571404

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  39 in total

1.  Analysis of the effect of intravesical treatment with interferon-alpha 2b on the clinical evolution and on the in vivo function of T lymphocytes and natural killer cells in patients with superficial bladder tumors.

Authors:  J Carballido; L M Moltó; C Olivier; L Manzano; M Alvarez-Mon
Journal:  Anticancer Drugs       Date:  1992-05       Impact factor: 2.248

Review 2.  The interferon-macrophage alliance.

Authors:  S C Mogensen; J L Virelizier
Journal:  Interferon       Date:  1987

Review 3.  Immunomodulation by interferons: recent developments.

Authors:  J De Maeyer-Guignard; E De Maeyer
Journal:  Interferon       Date:  1985

4.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.

Authors:  G R Foster; A M Ackrill; R D Goldin; I M Kerr; H C Thomas; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

5.  Antagonistic effects of interferons on the cytotoxicity mediated by natural killer cells.

Authors:  G Trinchieri; D Santoli; D Granato; B Perussia
Journal:  Fed Proc       Date:  1981-10

6.  Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder.

Authors:  J Carballido; M Alvarez-Mon; O J Solovera; L Menéndez-Ondina; A Durántez
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

7.  Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.

Authors:  J A Carballido; L M Moltó; L Manzano; C Olivier; O J Salmerón; M Alvarez de Mon
Journal:  Cancer       Date:  1993-09-01       Impact factor: 6.860

8.  Different interactions of interferon-alpha subtypes at the surface of epithelial and lymphoid cells.

Authors:  M L Overall; P Chambers; P J Hertzog
Journal:  J Interferon Res       Date:  1992-08

9.  Diminished natural killer activity in pregnancy: modulation by interleukin 2 and interferon gamma.

Authors:  S Vaquer; A de la Hera; J Jordá; C Martínez; M Escudero; M Alvarez-Mon
Journal:  Scand J Immunol       Date:  1987-12       Impact factor: 3.487

10.  Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.

Authors:  M Cebrián; E Yagüe; M O de Landázuri; M Rodíguez-Moya; M Fresno; N Pezzi; S Llamazares; F Sánchez-Madrid
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.